Early switch from intravenous to oral antibiotic therapy in patients with cancer who have low-risk neutropenic sepsis: the EASI-SWITCH RCT
Vicky M. Coyle(Queen's University Belfast), Ronan McMullan(Belfast Health and Social Care Trust), D. Storey(Western General Hospital), Richard Adams(Velindre Cancer Centre), Ian Chau(Royal Marsden NHS Foundation Trust), Annmarie Doran(Belfast Health and Social Care Trust), Caroline Forde(Queen's University Belfast), Daniel F. McAuley(Queen's University Belfast), Glenn Phair(Belfast Health and Social Care Trust), Margaret Grayson(The Northern Ireland Cancer Centre), Ruth Plummer(National Health Service), Richard H. Wilson(Arizona State University), Anne Thomas(Leicester Royal Infirmary), Mike Clarke(University College Dublin), Clíona McDowell, Ashley Agus(Belfast Health and Social Care Trust), Rosemary A. Barnes(Innsbruck Medical University)
Cited by 4
Related Papers
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k